-

Hims & Hers Launches New Line of Mental Wellness Supplements, With More Options to Help Support Stress, Sleep and Lack of Focus

Unique and deliberate formulations combined with innovative form factors provide consumers with a more personalized wellness supplement experience

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched three new supplements that are designed to help consumers support their mental wellness, including sleep, stress, and lack of focus. These new wellness supplements are now available on forhims.com and forhers.com, as well as select Target and Walgreens stores and UrbanOutfitters.com.

“The last two years have been extremely trying on us all, leading to new and increased feelings of anxiety and stress, lack of focus and difficulty getting a good night’s sleep,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “We want to continue to empower our consumers by providing them with the right product to help them start the year strong and supported, no matter where they are within their wellness journey.”

Consumers will now have three additional supplement options to help support their mental wellness:

  • Mind Unwind - designed for those looking for a natural way to decompress and relax, these vegan, non-GMO drops include B6, L-theanine, and 5-HTP to help improve mood, chamomile and catnip leaf to help calm the body and adaptogens rhodiola and ashwagandha to help the body manage stress. These stone fruit and lavender-flavored drops, which can be added to a beverage or directly on the tongue, allow for a convenient way to destress at home or on-the-go.
  • Double Doze - made for those who are looking for a better night’s sleep and are seeking another supplement option beyond our melatonin gummy offering. These gluten-free, non-GMO capsules, are coated in lavender essential oil and release melatonin over the course of approximately 6 hours. Comprised of a unique formulation of GABA, magnesium and two forms of melatonin (2mg for immediate release and 2mg of sustained release), these capsules help consumers get a full night of quality sleep without feeling fuzzy the next morning. Other ingredients like L-theanine, valerian root, ashwagandha, schisandra and clary sage oil help to destress and relax.
  • Focus Finder - created for those looking for a more natural method to heighten mental clarity and sharpen focus. These spearmint-scented, gluten-free, non-GMO capsules include innovative beadlets that release 25mg of caffeine derived from green tea extract over the course of approximately 3 hours. This unique and deliberate formulation of caffeine and L-theanine allows for calm energy and sustained focus while Niacin and B12 keep the nervous system healthy. Other ingredients like ginseng helps improve mental focus and ashwagandha helps the body manage stress while DHA helps support brain health. Focus Finder capsules, which each contain as much caffeine as a cup of green tea, can be taken up to 3 at a time to help get in the zone and skip the crash.

The Double Doze capsules features an innovative form factor that delivers ingredients in two different ways, through oil and beadlets in the capsule, to let them work in the body over a series of hours for longer lasting effect.

In addition to these new supplements, the company offers a wide variety of supplements including immunity and sleep gummy vitamins, unflavored collagen protein powder and biotin gummies for both Hims & Hers customers. For more information about our supplement offerings, please visit https://www.forhers.com/well-being or https://www.forhims.com/well-being.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Jess Haro-Rodriguez
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers launched three new supplements designed to help consumers support their mental wellness, including sleep, stress, and lack of focus.
Release Versions

Contacts

Jess Haro-Rodriguez
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its international expansion efforts. Personalized treatment plans are available starting at $149 CAD/month, making...

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD. GLP-1 treatments have transformed obesity and metabolic health, with...

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced of...
Back to Newsroom